The effect of risk factors on surgical and oncological results in high-risk prostate cancer: A multicentre study of the urooncology society, Turkey

被引:1
作者
Izol, Volkan [1 ]
Akdogan, Nebil [1 ]
Ozen, Haluk [2 ]
Akdogan, Bulent [2 ]
Kural, Ali Riza [3 ]
Tuna, Mustafa Bilal [3 ]
Sozen, Sinan [4 ]
Turkeri, Levent [5 ]
Tansug, Mustafa Zuhtu [1 ]
机构
[1] Cukurova Univ, Fac Med, Dept Urol, TR-01330 Adana, Turkey
[2] Hacettepe Univ, Fac Med, Dept Urol, Ankara, Turkey
[3] Acibadem Univ, Acibadem Maslak Hosp, Dept Urol, Istanbul, Turkey
[4] Gazi Univ, Fac Med, Dept Urol, Ankara, Turkey
[5] Acibadem Univ, Altunizade Hosp, Dept Urol, Istanbul, Turkey
关键词
RADICAL PROSTATECTOMY; SURVIVAL; MORTALITY; THERAPY; OUTCOMES; IMPACT; MEN;
D O I
10.1111/ijcp.14281
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Purpose To evaluate the effect of risk factors and selected surgical methods on operative and oncological results of patients undergoing radical prostatectomy (RP) with high-risk prostate cancer (HRPC). Methods Retrospective analysis of patients who underwent RP for HRPC from 13 urology centres between 1990 and 2019 was performed. Groups were created according to the risk factors of D'Amico classification. Patients with one risk factor were included in group 1 where group 2 consisted of patients with two or three risk factors. Results A total of 1519 patients were included in this study and 1073 (70.6%) patients were assigned to group 1 and 446 (29.4%) patients to group 2. Overall (biochemical and/or clinical and/or radiological) progression rate was 12.4% in group 1 and 26.5% in group 2 (P = .001). Surgical procedure was open RP in 844 (55.6%) patients and minimally invasive RP in 675 (44.4%) patients (laparoscopic and robot-assisted RP in 230 (15.1%) and 445 (29.3%) patients, respectively). Progression rates were similar in different types of operations (P = .22). Progression rate was not significantly different in patients who either underwent pelvic lymph node dissection (PLND) or not in each respective group. Conclusion RP alone is an effective treatment in the majority of patients with HRPC and PLND did not affect the progression rates after RP. According to the number of pre-operative high-risk features, as the number of risk factors increases, there is a need for additional treatment.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Long-term oncological results of treatment for high-risk prostate cancer using radical prostatectomy in a cancer hospital
    Rubio-Briones, J.
    Ramirez-Backhaus, M.
    Gomez-Ferrer, A.
    Mir, C.
    Dominguez-Escrig, J.
    Collado, A.
    Iborra, I.
    Casanova, J.
    Solsona, E.
    Mascaros, J. M.
    Calatrava, A.
    ACTAS UROLOGICAS ESPANOLAS, 2018, 42 (08): : 507 - 515
  • [2] The effect of body mass index on oncological and surgical outcomes in patients undergoing radical cystectomy for bladder cancer: A multicentre study of the association of urooncology, Turkey
    Izol, Volkan
    Deger, Mutlu
    Baltaci, Sumer
    Akgul, Murat
    Selvi, Ismail
    Ozden, Ender
    Suer, Evren
    Tansug, Mustafa Zuhtu
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2021, 75 (03)
  • [3] Surgery for high-risk prostate cancer and metastatic prostate cancer
    Safir, Ilan J.
    Lian, Fei
    Alemozaffar, Mehrdad
    Master, Viraj A.
    CURRENT PROBLEMS IN CANCER, 2015, 39 (01) : 33 - 40
  • [4] Laparoscopic Radical Prostatectomy in Patients with High-Risk Prostate Cancer: Feasibility and Safety. Results of a Multicentric Study
    Varca, Virginia
    Benelli, Andrea
    Perri, Davide
    Gozen, Ali Sedar
    Fiedler, Marcel
    de la Taille, Alexandre
    Casazza, Giovanni
    Salomon, Laurent
    Rassweiler, Jens
    Gregori, Andrea
    Gaboardi, Franco
    JOURNAL OF ENDOUROLOGY, 2018, 32 (09) : 843 - 851
  • [5] Comparative effectiveness of treatments for high-risk prostate cancer patients
    Jayadevappa, Ravishankar
    Lee, David I.
    Chhatre, Sumedha
    Guzzo, Thomas J.
    Malkowicz, Stanley B.
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2019, 37 (09) : 574.e11 - 574.e18
  • [6] High-risk prostate cancer: the role of surgical management
    Morlacco, Alessandro
    Karnes, R. Jeffrey
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 102 : 135 - 143
  • [7] The epidemiology of high-risk prostate cancer
    Punnen, Sanoj
    Cooperberg, Matthew R.
    CURRENT OPINION IN UROLOGY, 2013, 23 (04) : 331 - 336
  • [8] Localized intermediate- to high-risk prostate cancer
    Tritschler, S.
    Ganswindt, U.
    Stief, C. G.
    UROLOGE, 2016, 55 (03): : 318 - +
  • [9] Oncological results of neoadjuvant chemohormonal therapy in patients with high and very high-risk prostate cancer
    Berkut, M., V
    Artemjeva, A. S.
    Reva, S. A.
    Tolmachev, S. S.
    Petrov, S. B.
    Nosov, A. K.
    ONKOUROLOGIYA, 2020, 16 (01): : 54 - 63
  • [10] High-risk prostate cancer: The oncological efficiency of radical prostatectomy
    Veliyev, E. I.
    Sokolov, E. A.
    Loran, O. B.
    Petrov, S. B.
    ONKOUROLOGIYA, 2014, 10 (01): : 53 - 57